Form 4: Biofrontera Inc. CEO Hermann Luebbert Reports Stock Transactions
SEC Form 4 Filing
CEO Hermann Luebbert reports the conversion of restricted stock units into common stock and subsequent disposal of shares on May 18, 2024.
Summary
- On May 18, 2024, Hermann Luebbert, CEO and Executive Chairman of Biofrontera Inc., converted 4,771 restricted stock units into common stock.
- Following the conversion, Mr. Luebbert disposed of 4,771 shares of common stock.
- The reported transactions were made pursuant to a pre-arranged Rule 10b5-1(c) trading plan.
- Mr. Luebbert directly owns 15,211 shares of Biofrontera Inc. common stock after the reported transactions.
- All share amounts have been adjusted for the reverse stock split that occurred on June 28, 2023.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, reporting stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transactions.
Industry Context
Executive stock transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. Transactions under 10b5-1 plans are less informative as they are pre-arranged.
Stakeholder Impact
- Shareholders may be interested in the CEO's stock transactions as an indicator of management's confidence in the company.
- However, since the transactions were made under a pre-arranged trading plan, the impact on stakeholder perception may be limited.
Key Dates
| Date | Description |
|---|---|
| May 18, 2022 | Reporting person was granted 9,542 restricted stock units, vesting in two equal annual installments beginning on May 18, 2023. |
| May 18, 2023 | First vesting date for restricted stock units granted on May 18, 2022. |
| June 28, 2023 | Reverse stock split occurred. |
| May 18, 2024 | CEO converted 4,771 restricted stock units into common stock and disposed of 4,771 shares. |
| May 22, 2024 | Date of Form 4 signature. |
Keywords
Biofrontera Inc., Hermann Luebbert, stock transaction, Form 4, restricted stock units, common stock, beneficial ownership, reverse stock split, Rule 10b5-1(c)
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.